Group items tagged

We know remuneration influences behaviour. If I have a construction company and I pay a bricklayer a fee per brick to supply and fit, I suspect he will source them from the cheapest supplier and lay as many bricks as he possibly can. If one day, I reduce the fee such that it barely covers the cost of the brick, at a time when bricks are in short supply and labour costs have gone up, oh and I take some money off him for the profit he made on bricks he supplied the previous year, I suspect he will tell me to stick my job where the sun doesn't shine. It may be a crude analogy, but it is pretty much what's happened in community pharmacy over the last 20 years. The remuneration we get for dispensing does not cover the cost of providing the service. The reimbursement for the drugs does not cover the cost of the drugs. In fact, we make a loss on many items given all the clawbacks and supply shortages. Wages have gone up. And then each year the government claws back profit they say we've made, apparently! Yet, despite all this, we continue providing the service under this archaic system, allowing our paymaster to repeat the injustice because they know they can and, unlike the bricklayer, we will just suck it up and take it. So, what makes us carry on like this? Is it our conscience towards patient care? Is it that we don't know what else to do and the fear of the unknown? Or is it like the boiling frog story, where the temperature has increased gradually around us that we haven't noticed the government heat slowly killing community pharmacy. I suspect the answer is a mixture of all these factors. The pain is somewhat masked when we see fee paying services

French drugmaker Sanofi will make 30 of its treatments, including insulin, available on a not-for-profit basis in 40 lower-income countries in the first step of its plan to increase access to its medicines worldwide. The treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the commercial business. The plan also includes the $25 million Impact fund, which will go towards supporting local start-up healthcare businesses and providing training on using the medicines, Sanofi said. "There's a lot of noise at the moment from different companies jumping into this space… but investing in entrepreneurship, in the ecosystem, is a new thing," said Jon Fairest, who heads the global health unit. The treatments available are on the World Health Organization's essential medicines list, and insulin in particular has been singled out by the UN agency as a life-saving medicine for diabetics that is difficult to access in many lower-income countries, where the burden of disease is growing.

Surrogate motherhood is an option for couples who are unable to have children, whether it be from age, infertility, or some other medical issue. It is also for women who can have children but choose not to have the pregnancy experience. The other option for women to have children is via adoption. Surrogacy can be accomplished by one, of two ways. In most cases, a man's sperm is instilled into the surrogate by a procedure called artificial insemination. If this is done, the surrogate is considered to be the biological and birth mother of the child. Another name for this type of surrogacy is traditional surrogacy. The other way surrogacy may be accomplished is by the man's sperm and woman's eggs being implanted into the surrogate. This process is known as vitro fertilization. In this case, the surrogate is not the biological mother but is still considered the birth mother of the child. This type of surrogacy is gestational surrogacy. Surrogacy has both supporters and opponents, and both parties have strong arguments that work in their favor. All that are against surrogacy feel it is unnecessary and it dismembers a woman's body, especially considering that surrogacy is a profitable transaction. Many build their belief against surrogacy on their religious beliefs, while others base it on political and legal beliefs. Roman Catholics are strongly against surrogacy and feel surrogacy takes away from the sacredness of marriage and the connection between father, mother, and child. They also feel that commercial surrogacy is greatly offensive. In commercial surrogacy, a child's birth is turned into a financial matter. They feel it turns women into reproductive robots and exploitation of children. Other groups that oppose to surrogacy are feminists. Many feminists will argue that surrogate women are pressured or forced into being surrogates when they really do not want to be. Feminists have even gone so far as to call surrogacy a reproductive prostitution. On

The business landscape worldwide is undergoing a significant transformation, shifting from a sole focus on profitability to incorporating a broader spectrum of considerations. Today, Environmental, Social, and Governance (ESG) criteria are integral to business operations, reflecting a commitment to sustainable and ethical practices alongside financial growth. ESG stands for three interconnected pillars: Environmental, focusing on reducing a company's ecological footprint; Social, addressing the impact on employees, diversity, equity, inclusion, and the broader community; and Governance, which ensures responsible management practices, ethical behavior, and compliance with regulations. This holistic approach is becoming a critical foundation for long-term success in various industries, including healthcare. For the UK healthcare and pharmacy sectors, integrating ESG not only aligns with global sustainability goals but also offers substantial benefits. This article delves into the specific implications of ESG for UK pharmacies, highlighting how they can leverage these practices to foster both community well-being and business success.

MCAN Health, a medical travel company based in Istanbul-Turkey, has announced its sponsorship of National Pharmacy Association (NPA), a not-for-profit organisation representing independent community pharmacies across the UK. Gulsultan Dogan, the Founder and CEO of MCAN Health, said that their company is dedicated to improving global healthcare accessibility, which aligned perfectly with the NPA's mission to boost community health services in the United Kingdom. On receiving the invitation letter from the NPA, Dogan said: "We did not hesitate to show our support and positively answer the invitation letter. "As a professional in the healthcare sector for years, I firmly believe medical care is a human right that should be accessible to everyone without enduring lengthy waiting lists."

A key person is an individual who contributes significantly to the success of the business due to their skills, knowledge, experience, and business acumen. In most community pharmacy businesses, which are usually owner managed, the key person(s) are the directors who are also usually the owners of the business. In large organisations, key person(s) could be found at various levels of the overall organisation structure such as managing directors, top salespeople, or technical experts. If you are diagnosed with a critical illness that results in you being unable to work, the financial security of your company, your co-directors and family members involved, could be jeopardised. It could also threaten everything you have worked so hard to build over the years. Where you own shares in the business, what would happen to your shares in case of critical illness or death? In the event of your death, your family would inherit your shares, but it would be impossible for them to take over your role in the business as they may not have the necessary skills or qualifications. There are a few other options available: The family can take a share of profits from the company, but this might be much less if the company is struggling because of your absence. The family could wind up the company and receive a share of its residual value. Sell the shares to your co-directors but they may not have the funds available to be able to purchase your shares. Sell the business on the open market but this would depend on finding a buyer who is prepared to pay the asking price and this could be a long, difficult, and costly process.

The strength of any organisation lies in its people. This being a common norm in the world of business, several of them are taking healthy initiatives and opening discussions around gender diversity and equality. Panelists during a session on Empowering Women In the Workplace held during the Pharmacy Business Diversity Conference on Thursday (December 9), agreed that having gender diversity in business, not just benefits women, but the whole organisation. "It drives engagement, diversity of thinking and ultimately performance," said Ifti Khan, pharmacy superintendent at Well Pharmacy, in the session moderated by the conference chair and BBC presenter Clive Myrie. To substantiate his point, he cited a recent report by McKinsey & Company, as per which companies in the top quartile for ethnic and cultural diversity are 36 per cent more profitable than those in the fourth quartile.

Lack of appropriate funding is making survival a massive challenge for community pharmacy, a sector relied upon as a vital support system by both primary and secondary care in England. The Telegraph newspaper ran a story on Monday (August 22) which highlighted the dire straits community pharmacy finds itself in. Seasoned pharmacist Ian Strachan told the paper: "Our four pharmacies were the only point of call that was open (during Covid). We were there every single day, even when the virus was prevalent and people were dying." Describing the current situation, he said: "What is happening is we're facing a system that's just not working at all in our favour." Strachan says the issue is that pharmacists are "just not getting the help we need to be able to do this job properly". The sector is hugely dependent on funding from the NHS. The government had agreed in 2019 to set £2.6bn as annual funding for the sector. However, according to a report from EY that amount was already down £200m on the 2016 levels of government funding. "We've been starved of appropriate funding since 2016," Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies told The Telegraph. "It looks grim for businesses. The fees pharmacists get are going nowhere, but now, there's higher utility bills, higher staff fees and higher drug costs."

It does not matter if you are a large and thriving hospital, a tiny startup clinic or a small private practice, you will find that medical equipment is a necessity for your business. This equipment will need to be dependable, high quality and top notch to keep you profitable.

Ochsner is led by the President and CEO, Warner Thomas - a leader with a strategic vision. He exemplifies courage in a time of change to ensure that the organization positively embraces disruption and continues to move in the right direction that is best for its patients.